|
5 |
Comparison of macrophage immune responses and metabolic reprogramming in smooth and rough variant infections of Mycobacterium mucogenicum
|
년도2022 |
저널Int J Mol Sci |
https://www.mdpi.com/1422-0067/23/5/2488
|
|
4 |
Early Bactericidal Activity of Delpazolid (LCB01-0371) in Patients with Pulmonary Tuberculosis
|
년도2022 |
저널Antimicrob Agents Chemother |
https://journals.asm.org/doi/full/10.1128/aac.01684-21
|
|
3 |
Novel Antibacterial Activity of Febuxostat, an FDA-Approved Antigout Drug against Mycobacterium tuberculosis Infection
|
년도2022 |
저널Antimicrob Agents Chemother. |
https://journals.asm.org/doi/10.1128/aac.00762-22
|
|
2 |
Early bactericidal activity of delpazolid(LCB01-0371) in patients with pulmonary tuberculosis
|
년도2022 |
저널Antimicrob Agents Chemother |
https://journals.asm.org/doi/full/10.1128/aac.01684-21
|
|
1 |
Comparison of macrophage immune responses and metabolic reprogramming in somooth and rough variant infections of Mycobacterium mucogenicum
|
년도2022 |
저널International Journal of Molecular Sciences |
https://www.mdpi.com/1422-0067/23/5/2488
|
